Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 4–4 | Cite as

Nitrosamine impurities in angiotensin receptor blockers

News item
  • 1 Downloads

Reference

  1. Woodcock J. Statement on the agency's ongoing efforts to resolve safety issue with ARB medications. Internet Document : 28 Aug 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-agencys-ongoing-efforts-resolve-safety-issue-arb-medications

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations